BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25449034)

  • 1. Inhibitory effects of cortisone and hydrocortisone on human Kv1.5 channel currents.
    Yu J; Park MH; Jo SH
    Eur J Pharmacol; 2015 Jan; 746():158-66. PubMed ID: 25449034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisone and hydrocortisone inhibit human Kv1.3 activity in a non-genomic manner.
    Yu J; Park MH; Choi SY; Jo SH
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):653-61. PubMed ID: 25743574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of hesperetin on Kv1.5 potassium channels stably expressed in HEK 293 cells and ultra-rapid delayed rectifier K(+) current in human atrial myocytes.
    Wang H; Wang HF; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
    Eur J Pharmacol; 2016 Oct; 789():98-108. PubMed ID: 27397430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effects of levo-tetrahydropalmatine on rat Kv1.5 channels expressed in HEK293 cells.
    Li K; Pi MS; Li XT
    Eur J Pharmacol; 2017 Aug; 809():105-110. PubMed ID: 28502629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.
    Jeong I; Choi BH; Yoon SH; Hahn SJ
    Biochem Pharmacol; 2012 Feb; 83(4):497-505. PubMed ID: 22146582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade action of ketanserin and increasing effect of potassium ion on Kv1.3 channels expressed in Xenopus oocytes.
    Wang X; Liao Y; Zou A; Li L; Tu D
    Pharmacol Res; 2007 Aug; 56(2):148-54. PubMed ID: 17582781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aconitine blocks HERG and Kv1.5 potassium channels.
    Li Y; Tu D; Xiao H; Du Y; Zou A; Liao Y; Dong S
    J Ethnopharmacol; 2010 Aug; 131(1):187-95. PubMed ID: 20600762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-dioxin-like polychlorinated biphenyl 19 has distinct effects on human Kv1.3 and Kv1.5 channels.
    Kim JH; Hwang S; Jo SH
    Toxicol Appl Pharmacol; 2021 Jan; 411():115365. PubMed ID: 33316272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of Conorfamide-Sr3 on Human Voltage-Gated Kv1 Potassium Channel Subtypes.
    López-Vera E; Martínez-Hernández L; Aguilar MB; Carrillo E; Gajewiak J
    Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32823677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Human Kv1.4 Channel Activity by the Antidepressant Metergoline.
    Yeom HD; Lee JH
    Biol Pharm Bull; 2016; 39(6):1069-72. PubMed ID: 27251511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment.
    Yang L; Ma JH; Zhang PH; Zou AR; Tu DN
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):154-61. PubMed ID: 18986330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
    Lagrutta A; Wang J; Fermini B; Salata JJ
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
    Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation.
    Decher N; Kumar P; Gonzalez T; Pirard B; Sanguinetti MC
    Mol Pharmacol; 2006 Oct; 70(4):1204-11. PubMed ID: 16835355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electropharmacological properties of telmisartan in blocking hKv1.5 and HERG potassium channels expressed on Xenopus laevis oocytes.
    Tu DN; Liao YH; Zou AR; Du YM; Run Q; Wang XP; Li L
    Acta Pharmacol Sin; 2008 Aug; 29(8):913-22. PubMed ID: 18664324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
    Arias C; Guizy M; David M; Marzian S; González T; Decher N; Valenzuela C
    Anesthesiology; 2007 Oct; 107(4):641-51. PubMed ID: 17893461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Inhibition of the Human Kv1.5 Channel by H
    Park SI; Hwang S; Kim JH; Yang SR; Jo SH
    Biol Pharm Bull; 2023; 46(10):1394-1402. PubMed ID: 37779040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum albumin attenuates the open-channel blocking effects of propofol on the human Kv1.5 channel.
    Kojima A; Bai JY; Ito Y; Ding WG; Kitagawa H; Matsuura H
    Eur J Pharmacol; 2016 Jul; 783():117-26. PubMed ID: 27164421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of voltage gated K⁺ channel Kv1.5 by β-catenin.
    Munoz C; Tóvolli RH; Sopjani M; Alesutan I; Lam RS; Seebohm G; Föller M; Lang F
    Biochem Biophys Res Commun; 2012 Jan; 417(2):692-6. PubMed ID: 22166221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of Kv1.5 channel block by diphenyl phosphine oxide-1.
    Du YM; Zhang XX; Tu DN; Zhao N; Liu YJ; Xiao H; Sanguinetti MC; Zou A; Liao YH
    J Mol Cell Cardiol; 2010 Jun; 48(6):1111-20. PubMed ID: 20184887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.